However, tumours carrying somatic deleterious/missense TP53 variants showed higher counts of stromal CD3+ (p = 0.031), CD4+ (p = 0.04), and FOXP3+ (p = 0.02); (Fig. 3). This evidence concerns the gene TP53 and neoplasm.